OncoCyte Corporation (OCX) News
Filter OCX News Items
OCX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OCX News Highlights
- OCX's 30 day story count now stands at 6.
- Over the past 17 days, the trend for OCX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- API, GENE and LUNG are the most mentioned tickers in articles about OCX.
Latest OCX News From Around the Web
Below are the latest news stories about ONCOCYTE CORP that investors may wish to consider to help them evaluate OCX as an investment opportunity.
OncoCyte Corporation – Consensus Indicates Potential 84.4% UpsideOncoCyte Corporation with ticker code (OCX) now have 4 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The range between the high target price and low target price is between 1.4 and 0.4 and has a mean target at 0.83. With the stocks previous close at 0.45 this now indicates there is a potential upside of 84.4%. The 50 day MA is 0.43 and the 200 moving average now moves to 0.83. The market capitalisation for the company is $54m. Visit the company website at: https://oncocyte.com [stock_market_widget type="chart" template="basic" color="green" assets="OCX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $100m based on the market concensus. OncoCyte Corporation, a molecular diagnostics company, researches, dev... |
Dazzling stocks: American Airlines Group Inc. (NASDAQ:AAL 1.52%), OncoCyte Corporation (NASDAQ:OCX -0.11%)There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Dazzling stocks: American Airlines Group Inc. (NASDAQ:AAL 1.52%), OncoCyte Corporation (NASDAQ:OCX -0.11%) appeared first on Stocks Equity . |
A Business Review Of OncoCyte Corporation (NASDAQ: OCX) And Growth ForecastIn the last trading session, 0.26 million shares of the OncoCyte Corporation (NASDAQ:OCX) were traded, and its beta was 1.72. Most recently the company’s share price was $0.49, and it changed around $0.02 or 3.28% from the last close, which brings the market valuation of the company to $56.10M. OCX currently trades at a discount … A Business Review Of OncoCyte Corporation (NASDAQ: OCX) And Growth Forecast Read More » |
OncoCyte Corporation – Consensus Indicates Potential 97.6% UpsideOncoCyte Corporation found using ticker (OCX) now have 4 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The target price ranges between 1.4 and 0.4 with a mean TP of 0.83. Given that the stocks previous close was at 0.42 this now indicates there is a potential upside of 97.6%. The 50 day moving average now sits at 0.45 and the 200 moving average now moves to 0.85. The market cap for the company is $56m. You can visit the company''s website by visiting: https://oncocyte.com [stock_market_widget type="chart" template="basic" color="green" assets="OCX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $111m based on the market concensus. OncoCyte Corporation, a molecular diagnostics company, researches, develops... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayThe final day of trading this week is here and we're starting it off with a look at the biggest pre-market stock movers for Friday! |
How did OncoCyte Corporation (OCX) fare last session?A share of OncoCyte Corporation (NASDAQ:OCX) closed at $0.32 per share on Friday, down from $0.34 day before. While OncoCyte Corporation has underperformed by -5.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OCX fell by -84.27%, with highs and lows ranging from $2.26 to $0.24, […] |
OncoCyte Corporation (OCX) Looks Set To Grow At A Great Clip In 2023OncoCyte Corporation (NASDAQ:OCX) has a beta value of 1.62 and has seen 1.06 million shares traded in the last trading session. The company, currently valued at $40.09M, closed the last trade at $0.32 per share which meant it lost -$0.02 on the day or -5.06% during that session. The OCX stock price is -606.25% off … OncoCyte Corporation (OCX) Looks Set To Grow At A Great Clip In 2023 Read More » |
A stock that deserves closer examination: OncoCyte Corporation (OCX)A share of OncoCyte Corporation (NASDAQ:OCX) closed at $0.38 per share on Friday, up from $0.29 day before. While OncoCyte Corporation has overperformed by 28.99%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OCX fell by -83.48%, with highs and lows ranging from $2.33 to $0.24, […] |
OncoCyte''s Return On Capital Employed InsightsBenzinga Pro data, OncoCyte (NASDAQ: OCX ) reported Q3 sales of $1.02 million. Earnings fell to a loss of $9.33 million, resulting in a 12.45% decrease from last quarter. OncoCyte collected $2.07 million in revenue during Q2, but reported earnings showed a $8.30 million loss. Why Is ROCE Significant? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth of a company and is … Full story available on Benzinga.com |
Can you now get a good deal on OncoCyte Corporation’s shares?A share of OncoCyte Corporation (NASDAQ:OCX) closed at $0.28 per share on Monday, down from $0.31 day before. While OncoCyte Corporation has underperformed by -9.48%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OCX fell by -86.92%, with highs and lows ranging from $2.45 to $0.31, […] |